CN101928247B - Synthetic method of xylometazoline hydrochloride compound - Google Patents

Synthetic method of xylometazoline hydrochloride compound Download PDF

Info

Publication number
CN101928247B
CN101928247B CN2010102859651A CN201010285965A CN101928247B CN 101928247 B CN101928247 B CN 101928247B CN 2010102859651 A CN2010102859651 A CN 2010102859651A CN 201010285965 A CN201010285965 A CN 201010285965A CN 101928247 B CN101928247 B CN 101928247B
Authority
CN
China
Prior art keywords
dimethyl
tertiary butyl
mole
reactions step
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2010102859651A
Other languages
Chinese (zh)
Other versions
CN101928247A (en
Inventor
邓军
黄璐
郭亚兵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei Grand Everyday Bright Eyes Pharmaceutical Co ltd
Original Assignee
Wuhan Wuyao Science & Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wuhan Wuyao Science & Technology Co ltd filed Critical Wuhan Wuyao Science & Technology Co ltd
Priority to CN2010102859651A priority Critical patent/CN101928247B/en
Publication of CN101928247A publication Critical patent/CN101928247A/en
Application granted granted Critical
Publication of CN101928247B publication Critical patent/CN101928247B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The invention relates to a method for synthesizing a compound xylometazoline hydrochloride, which takes 1, 3-dimethyl-5-tert-butyl benzene as an initial raw material and obtains xylometazoline hydrochloride through chloromethylation, cyanation, cyclization and salification. The synthesis method is simple, the raw materials are easy to obtain, the operation is safe, the yield is high, and the method is suitable for industrial production.

Description

A kind of compound method of xylometazoline hydrochloride compound
Technical field
The invention belongs to the synthetic field of medicine, be specifically related to a kind of compound method of xylometazoline hydrochloride compound.
Background technology
Xylometazoline hydrochloride (Xylometazoline Hydrochloride, 1), chemistry is by name: 2-(the 4-tertiary butyl-2,6-dimethyl benzyl)-2-imidazoline salt hydrochlorate, its chemical structure is following.Xylometazoline hydrochloride has direct exciting α 1 acceptor and causes vasoconstrictive effect, thus hyperemia due to reducing inflammation and oedema, clinically in order to alleviate the nasal obstruction symptom that diseases such as acute and chronic rhinitis, sinusitis paranasal sinusitis, allergic rhinitis, hypertrophic rhinitis cause.
Figure BSA00000275521500011
In the prior art, US6124338 discloses a kind of method for preparing xylometazoline, by 2; 6-dimethyl--4-the tertiary butyl-1-aniline (2) gets 2 with polyformaldehyde reaction after diazotization, the 6-dimethyl--4-tertiary butyl-1-phenyl aldehyde (3) gets 2 with sodium borohydride reduction then; 6-dimethyl--4-the tertiary butyl-1-phenylcarbinol (4), hydroxyl becomes chlorine in the presence of sulfur oxychloride, gets 2; 6-dimethyl--4-the tertiary butyl-1-chloromethylbenzene (5); After reacting in ethanol with sodium cyanide compound (7), last and quadrol cyclization obtains target compound (1), its reaction formula is following:
Figure BSA00000275521500021
Diazotization reaction in this compound method, general yield is not high; And use sulfur oxychloride that environment is had very big pollution; The aftertreatment of cyanation need be carried out the high-vacuum fractionation distillation, is difficult to amplify produce.The product impurity of this patented process gained is many, and it is low particularly to prepare the product purity of (1) by compound (7).In a word, this synthetic method craft route is long, and aftertreatment is loaded down with trivial details, and product yield is low, production cost is high, and this makes this difficult technique to realize industrialized production.
And ES323985 is disclosed by 1, and 3-dimethyl--5-tert.-butylbenzene (8) is prepared into the method for compound (5), and its chloromethylation is with ZnCl 2Make catalyzer, but this reaction conversion ratio is low, is merely 59%.
CN1088574 discloses the method by compound (8) preparation (5), adopts Paraformaldehyde 96, is catalyzer with the vitriol oil and feeds hydrogen chloride gas, yield 80-90%.Its reaction formula is following:
Figure BSA00000275521500022
The bullion impurity that this chloromethylation obtains is many, need carry out the high-vacuum fractionation distillation, and post-processing difficulty is big.In addition, this technology need feed a large amount of hydrogen chloride gas, causes the spent acid solution discharging to increase, and environment is had very big pollution.
Summary of the invention
The object of the invention is exactly to the prior art defective, provides that a kind of technology is simple, raw material is easy to get, operational safety, yield be high, is fit to the synthesis technique of the xylometazoline hydrochloride of suitability for industrialized production.
Technical scheme of the present invention is: with 1,3-dimethyl--5-tert.-butylbenzene (8) is a starting raw material, in the presence of catalyzer, gets 2 with the chloromethylation reagent react, the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene (5); Carry out cyanation with sodium cyanide and get 2, the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide (6); Get tosic acid xylometazoline (10) with quadrol tosilate (9) cyclization then; Xylometazoline is got xylometazoline hydrochloride (1) with the free back of alkali with the hydrogenchloride salify, and the total recovery of four-step reaction is 44%.
Synthetic route of the present invention is following:
Figure BSA00000275521500031
The concrete synthesis technique step of the present invention is following:
(a) chloromethylation: with 1; 3-dimethyl--5-tert.-butylbenzene (8) is as starting raw material; With compound (8): chloromethylation reagent: catalyst molar ratio is 1: (1.0~1.2): (0.1~0.2) feeds intake; Reacted 1~3 hour down at 40~60 ℃, aftertreatment gets 2, the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene (5);
(b) cyanation: with compound (5): sodium cyanide: the mol ratio of catalyzer is 1: (1.0~1.4): (0.02~0.08) feeds intake, reflux 14~22 hours, and aftertreatment and recrystallization get 2, the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide (6);
(c) ring-closure reaction: with compound (6) and quadrol tosilate (9) with 1: (1.0~1.3) mol ratio feeds intake, and is heated to 210~240 ℃ of reactions 0.5~2 hour, tosic acid xylometazoline (10).
(d) salt-forming reaction: compound (10) with alkali free after, again in organic solvent with the hydrogenchloride salify, regulate pH=4~5, xylometazoline hydrochloride (1) bullion, refining finished product.
In the above-mentioned reactions step (a), said chloromethylation reagent is one or more mixing in chloromethyl ether, bischlormethyl ether, the chloromethyl ether, preferred chloromethyl ether.
In the above-mentioned reactions step (a), said catalyzer is zinc chloride or aluminum trichloride (anhydrous).
In the above-mentioned reactions step (a), when temperature of reaction is 48~52 ℃, compound (8) is 1: 0.15 o'clock with catalyst molar ratio, reacts 2 hours, and the yield of compound (5) is the highest.
In the above-mentioned reactions step (b), said solvent is one or more mixing in acetone, butanone, methylene dichloride, trichloromethane, toluene, chlorobenzene or the diethyl carbonate, preferred acetone.
In the above-mentioned reactions step (b), said catalyzer is one or more mixing in potassiumiodide, Soiodin, potassiumiodide, Soiodin, Tetrabutyl amonium bromide, tetrabutylammonium iodide, tetraethylammonium bromide, the tetraethyl ammonium iodide, preferred potassiumiodide.
In the above-mentioned reactions step (c), preferred compound (6) is 1: 1.12 with the mol ratio of quadrol tosilate (9), and temperature of reaction is 220~230 ℃, and the reaction times is 1 hour.
In the above-mentioned reactions step (d), used alkali is one or more mixing in yellow soda ash, sodium hydrogencarbonate, sodium hydroxide, salt of wormwood, saleratus, Pottasium Hydroxide, sodium-acetate, ammoniacal liquor, SODIUM PHOSPHATE, MONOBASIC, the Sodium phosphate, dibasic.Preferred sodium hydroxide, Pottasium Hydroxide or ammoniacal liquor.
In the above-mentioned reactions step (d); Employed organic solvent is N; One or more mixing, ethyl acetate and ethanol mixed solvent in dinethylformamide, sherwood oil, ethanol, methyl alcohol, acetone, THF, ETHYLE ACETATE, methyl acetate, propyl acetate, isopropyl acetate, normal hexane, hexanaphthene, the methylene dichloride.
Synthesis technique of the present invention has been simplified operational process of craft, has improved xylometazoline hydrochloride midbody and final product quality, has reduced the discharging of spent acid solution, has improved production efficiency.
Synthesis technique particular embodiment of the present invention is in the following areas:
1) starting raw material 1, and 3-dimethyl--5-tert.-butylbenzene (8) is cheap and easy to get.
2) chloromethyl ether is active strong chloromethylation reagent, and transformation efficiency is high, and simultaneously, reaction product purity is high, and impurity is few, and reaction conditions is gentle.
3) compound (5) that obtains of chloromethylation need not purifying, can directly be used for next step reaction, has shortened the technological operation step, has improved yield.
4) cyanation mild condition, side reaction is few, and is simple to operate, is easy to aftertreatment, reduced labour intensity, improved Working environment.
5) solved the problem that is difficult to industrial amplification production in the patent route in the past.
6) product purity high (greater than 99.5%), yield high (total recovery 44%), quality reaches the newest standards of Chinese Pharmacopoeia, USP, British Pharmacopoeia, European Pharmacopoeia, Japanese Pharmacopoeia.
Embodiment
Following embodiment is used for further narrating the present invention, but does not do any restriction.
Embodiment 12, the preparation of the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene
With 1,3-dimethyl--5-tert.-butylbenzene 81 grams (0.5 mole) and aluminum trichloride (anhydrous) 13.4 grams (0.1 mole) mix, and slowly drip 41 gram chloromethyl ethers (0.5 mole), then 40-45 ℃ of reaction 3 hours.Drip 100 ml waters after reducing to room temperature, fully stir, behind the branch vibration layer; Organic layer is washed till pH=7 with saturated nacl aqueous solution, and anhydrous sodium sulfate drying gets oily matter 2 after the filtering and concentrating; 6-dimethyl--4-the tertiary butyl-1-chloromethylbenzene 88.4 grams (0.42 mole), yield 84%.
Embodiment 22, the preparation of the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene
With 1,3-dimethyl--5-tert.-butylbenzene 81 grams (0.5 mole) and zinc chloride 13.6 grams (0.1 mole) mix, and slowly drip 41 gram chloromethyl ethers (0.5 mole), then 45-50 ℃ of reaction 2.5 hours.Drip 120 ml waters after reducing to room temperature, post-treating method gets product 93.6 grams (0.44 mole), yield 89% with embodiment 1.
Embodiment 32, the preparation of the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene
With 1,3-dimethyl--5-tert.-butylbenzene 50 grams (0.31 mole) and zinc chloride 6.3 grams (0.046 mole) mix, and slowly drip chloromethyl ether 27 grams (0.34 mole), then 48-52 ℃ of reaction 2 hours.Drip 60 ml waters after reducing to room temperature, post-treating method gets product 59.6 grams (0.28 mole), yield 92% with embodiment 1.
Embodiment 42, the preparation of the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene
With 1,3-dimethyl--5-tert.-butylbenzene 81 grams (0.5 mole) and aluminum trichloride (anhydrous) 3.6 grams (0.05 mole) mix, and slowly drip 48 gram chloromethyl ethers (0.6 mole), then 50-55 ℃ of reaction 2 hours.Drip 900 ml waters after reducing to room temperature, post-treating method gets product 92.6 grams (0.44 mole), yield 88% with embodiment 1.
Embodiment 52, the preparation of the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene
With 1,3-dimethyl--5-tert.-butylbenzene 162 grams (1.0 moles) and zinc chloride 18 grams (0.13 mole) mix, and slowly drip 89 gram chloromethyl ethers (1.1 moles), then 50-55 ℃ of reaction 2 hours.Drip 220 ml waters after reducing to room temperature, post-treating method gets product 190.0 grams (0.90 mole), yield 90% with embodiment 1.
Embodiment 62, the preparation of the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene
With 1,3-dimethyl--5-tert.-butylbenzene 162 grams (1.0 moles) and zinc chloride 14 grams (0.1 mole) mix, and slowly drip 97 gram chloromethyl ethers (1.2 moles), then 55-60 ℃ of reaction 1 hour.Drip 250 ml waters after reducing to room temperature, post-treating method gets product 183.6 grams (0.87 mole), yield 87% with embodiment 1.
Embodiment 72, the preparation of the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide
Sodium cyanide 30.5 grams (0.62 mole), Soiodin 3.6 grams (0.024 mole) and 75 milliliters of acetone are added in the there-necked flask, stir down and drip 2, the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene 100 grams (0.48 mole), reflux is 18 hours then.Suction filtration is removed solid salt after reducing to room temperature, uses the small amount of acetone washing salt.Filtrating merges, and concentrating under reduced pressure, gained oily matter are cooled to 5 ℃ of crystallizations with 40 milliliters of dissolve with ethanol, gets 2 after the solid filtering drying, the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide 75.6 grams (0.38 mole), yield 79%.
Embodiment 82, the preparation of the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide
24 gram sodium cyanides (0.49 mole), 4 gram potassiumiodides (0.024 mole) and 400 milliliters of methylene dichloride are added in the there-necked flask, stir down and drip 2, the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene 100 grams (0.48 mole), reflux is 20 hours then.Post-treating method gets product 65.3 grams (0.32 mole), yield 68% with embodiment 7.
Embodiment 92, the preparation of the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide
Sodium cyanide 28 grams (0.57 mole), potassiumiodide 4 grams (0.024 mole) and 250 milliliters of acetone are added in the there-necked flask, stir down and drip 2, the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene 100 grams (0.48 mole), reflux is 20 hours then.Post-treating method gets product 76.4 grams (0.38 mole), yield 80% with embodiment 7.
Embodiment 10 2, the preparation of the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide
Sodium cyanide 23.5 grams (0.48 mole), potassiumiodide 1.6 grams (0.01 mole) and 250 milliliters of acetone are added in the there-necked flask, stir down and drip 2, the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene 100 grams (0.48 mole), reflux is 22 hours then.Post-treating method gets product 71.8 grams (0.36 mole), yield 75% with embodiment 7.
Embodiment 11 2, the preparation of the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide
Sodium cyanide 33 grams (0.67 mole), 5.7 gram Soiodins (0.038 mole) and 350 milliliters of acetone are added in the there-necked flask, stir down and drip 2, the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene 100 grams (0.48 mole), reflux is 14 hours then.Post-treating method gets product 71.6 grams (0.36 mole), yield 75% with embodiment 7.
The preparation of embodiment 12 tosic acid xylometazolines
With 2, the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide 50 grams (0.25 mole) and quadrol tosilate 75 grams (0.325 mole) mix, and are warming up to 210~220 ℃ of reactions 1.5 hours.Pour out while hot, the cooling after fixing gets tosic acid xylometazoline 99.6 grams (0.240 mole), yield 96%.
The preparation of embodiment 13 tosic acid xylometazolines
With 2, the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide 50 grams (0.25 mole) and quadrol tosilate 70 grams (0.30 mole) mix, and are warming up to 225~235 ℃ of reactions 1 hour.Post-treating method gets tosic acid xylometazoline 100.5 grams (0.242 mole), yield 97% with embodiment 12.
The preparation of embodiment 14 tosic acid xylometazolines
With 2, the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide 50 grams (0.25 mole) and quadrol tosilate 65 grams (0.28 mole) mix, and are warming up to 220~230 ℃ of reactions 1 hour.Post-treating method gets tosic acid xylometazoline 101.2 grams (0.243 mole), yield 98% with embodiment 12.
The preparation of embodiment 15 tosic acid xylometazolines
With 2, the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide (0.25 mole) and quadrol tosilate 58 grams (0.25 mole) mix, and are warming up to 230~240 ℃ of reactions 30 minutes.Post-treating method gets tosic acid xylometazoline 98.5 grams (0.237 mole), yield 95% with embodiment 12.
The preparation of embodiment 16 xylometazoline hydrochlorides
30 gram tosic acid xylometazolines (0.072 mole) are dissolved in 900 ml waters, are warming up to 90 ℃; Add 150 milliliter of 10% aqueous sodium hydroxide solution, stirred 30 minutes, reduce to the room temperature after-filtration; Filter cake is washed with water to washing lotion pH=7; The solid xylometazoline that after drying, must dissociate after the xylometazoline that will dissociate is dissolved in 150 milliliters of ETHYLE ACETATE, drips ethanol solution of hydrogen chloride to pH5.Use 50 milliliters of absolute ethyl alcohol heating for dissolving after the gained solid filtering drying again, the activated carbon decolorizing after-filtration, filtrating adds 135 milliliters of ETHYLE ACETATE; Be cooled to 5 ℃; Stir 1 hour after-filtration, filter cake washs with ETHYLE ACETATE, gets xylometazoline hydrochloride 12.4 grams (0.044 mole) after the drying; Yield 61%, purity 99.76% (performance liquid).
The preparation of embodiment 17 xylometazoline hydrochlorides
30 gram tosic acid xylometazolines (0.072 mole) are dissolved in 1000 ml waters, are warming up to 90 ℃; Add ammoniacal liquor, stirred 20 minutes, reduce to the room temperature after-filtration; Filter cake is washed with water to washing lotion pH=7; The solid xylometazoline that after drying, must dissociate after the xylometazoline that will dissociate is dissolved in 150 milliliters of ETHYLE ACETATE, drips ethanol solution of hydrogen chloride to pH4.Use 50 milliliters of absolute ethyl alcohol heating for dissolving after the gained solid filtering drying again, the activated carbon decolorizing after-filtration, filtrating adds 150 milliliters of ETHYLE ACETATE; Be cooled to 10 ℃; Stir 1 hour after-filtration, filter cake washs with ETHYLE ACETATE, gets xylometazoline hydrochloride 11.8 grams (0.042 mole) after the drying; Yield 58%, purity 99.80% (performance liquid).

Claims (1)

1. the compound method of an xylometazoline hydrochloride compound, this method comprises the steps:
(a) chloromethylation: with 1,3-dimethyl--5-tert.-butylbenzene is a starting raw material, in the presence of catalyzer, gets 2 with the chloromethylation reagent react, the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene;
The reagent of chloromethylation described in the reactions step a is chloromethyl ether,
Catalyzer described in the reactions step a is zinc chloride or aluminum trichloride (anhydrous),
Among the reactions step a 1,3-dimethyl--5-tert.-butylbenzene: chloromethylation reagent: catalyst molar ratio is 1: 1.0~1.2: 0.1~0.2,
Temperature of reaction is at 40~60 ℃ among the reactions step a;
(b) cyanation: 2, the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene and sodium cyanide in the presence of catalyzer, react 2, the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide;
The said catalyzer of reactions step b is: Soiodin or potassiumiodide;
Among the reactions step b 2, the 6-dimethyl--4-tertiary butyl-1-chloromethylbenzene: sodium cyanide: the mol ratio of catalyzer is 1: 1.0~1.4: 0.02~0.08;
(c) ring-closure reaction: with 2, the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide mixes with the quadrol tosilate, and cyclization is carried out in heating, gets the tosic acid xylometazoline;
Among the reactions step c 2, the 6-dimethyl--4-tertiary butyl-1-benzyl cyanide: quadrol tosilate mol ratio is 1: 1.0~1.3,
Temperature of reaction is at 210~240 ℃ among the reactions step c;
(d) salt-forming reaction: tosic acid xylometazoline alkalization is for behind the free alkali, again in solvent with the hydrochloric acid salify, xylometazoline hydrochloride;
The said solvent of reactions step d is an ETHYLE ACETATE.
CN2010102859651A 2010-09-19 2010-09-19 Synthetic method of xylometazoline hydrochloride compound Active CN101928247B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102859651A CN101928247B (en) 2010-09-19 2010-09-19 Synthetic method of xylometazoline hydrochloride compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102859651A CN101928247B (en) 2010-09-19 2010-09-19 Synthetic method of xylometazoline hydrochloride compound

Publications (2)

Publication Number Publication Date
CN101928247A CN101928247A (en) 2010-12-29
CN101928247B true CN101928247B (en) 2012-05-09

Family

ID=43367728

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102859651A Active CN101928247B (en) 2010-09-19 2010-09-19 Synthetic method of xylometazoline hydrochloride compound

Country Status (1)

Country Link
CN (1) CN101928247B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103224468A (en) * 2013-05-10 2013-07-31 范强 Tetrahydrozoline synthesis method
CN103351343A (en) * 2013-07-12 2013-10-16 天津华津制药有限公司 Synthetic method for xylometazoline hydrochloride

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5969137A (en) * 1996-09-19 1999-10-19 Virginia Commonwealth University Benzylamidine derivatives with serotonin receptor binding activity

Also Published As

Publication number Publication date
CN101928247A (en) 2010-12-29

Similar Documents

Publication Publication Date Title
CN101891649B (en) Novel 3-cyano methyl benzoate preparing method
CN102557977A (en) Synthesis intermediate of erlotinib and preparation method thereof
CN112079848A (en) Synthesis method of baroxavir key intermediate
CN1042705A (en) 3,5-dimethyl-4-methoxypyridine derivatization method and be used for the novel intermediate product of this method for making
CN116253685B (en) A preparation method of tegorazan intermediate
CN101928247B (en) Synthetic method of xylometazoline hydrochloride compound
CN102911128A (en) Synthetic method of valsartan
CN103113240A (en) Process for directly synthesizing p-aminophenol through hydrogenation of nitrobenzene
US9145348B2 (en) Process for synthesizing a CETP inhibitor
CN102491953A (en) Method for synthesizing florfenicol midbody RT0131
CN101671309B (en) Synthesis method of 6-ethyl-4-hydroxyl-5-fluorine-2-cloro pyridine ammonium salt
CN104130128A (en) Synthetic method of phenoxyl acetate and intermediate thereof
CN104211652B (en) A kind of method preparing Plerixafor
RU2344124C1 (en) Method of 2-n-phenylamino-2-cyanoadamantane or its derivatives production
CN105884807A (en) Pinacol borate derivative preparation method and thioacetate compound preparation method
CN114315609B (en) Technological method for preparing cis-2-aminocyclohexanol
CN104497048A (en) Preparation method of minodronic acid
CN103193679B (en) The preparation method of rivastigmine intermediate (R)-N-ethyl-N-methylamino formic acid-3-(1-hydroxyethyl) phenyl ester
CN108707108A (en) A kind of 4,4`-(2- pyridine methylenes)Biphenol diacetate synthetic method
CN101503365B (en) Preparation of venlafaxine intermediate 1-[2-amino-1-(4-methoxy phenyl)ethyl] cyclohexanol
CN102086147B (en) Preparation method of substituted phenol
JP7689742B2 (en) 1,4-dihydro-4-oxoquinoline-2-carboxylates and methods for preparing 4-aminoquinoline compounds therefrom
CN103755706B (en) A kind of environment-friendly preparation method synthesizing folic acid
CN102030631A (en) Method for synthesizing alpha-ketoleucine calcium
CN101844989B (en) Preparation method for clofedanol and hydrochloride thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20101229

Assignee: HUBEI YUANDA TIANTIANMING PHARMACEUTICAL CO., LTD.

Assignor: Wuhan Wuyao Technology Co., Ltd.

Contract record no.: 2014420000053

Denomination of invention: Method for synthesizing xylometazoline hydrochloride compound

Granted publication date: 20120509

License type: Exclusive License

Record date: 20140428

LICC Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model
TR01 Transfer of patent right

Effective date of registration: 20211102

Address after: 430000 No. 28, high tech Industrial Park, Wuhan Economic and Technological Development Zone, Wuhan, Hubei Province

Patentee after: HUBEI GRAND EVERYDAY BRIGHT EYES PHARMACEUTICAL CO.,LTD.

Address before: 430035 Hubei province in Qiaokou District of Wuhan city Gutian Road No. 5

Patentee before: WUHAN WUYAO SCIENCE & TECHNOLOGY Co.,Ltd.

TR01 Transfer of patent right